Using Mycelium for a Sustainable Future feat. Kimberly Carlson
In this episode, David talks with Kimberly Carlson, CEO & CFO of Mushrooms Inc., a company that is aiming to bring forth a new era of sustainability with the use of mycelium.
Similar Posts
Efficacy of Ketamine for Depression and Other Mental Health Conditions: Top 10 Studies of 2023
55.4% of patients in the ketamine group exhibited a significant reduction in depressive symptoms.
In comparison, 41.2% of patients undergoing ECT showed similar improvement.
Interview with Rick Doblin, Executive Director and Founder of MAPS
In this episode, Rick and James Hallifax discuss MAPS’ work treating PTSD with MDMA, sending the Soviets Psychedelics, and what the future holds.
How Magic Mushrooms Affect the 5 Senses
While magic mushrooms don’t alter your senses directly, they modify how your brain processes external stimuli, heightening sensations or producing deep emotional reactions.
Psychedelics Aiding Recovery with Arrowyn Ambrose
In this episode, Arrowyn speaks on how psychedelics are integrated into recovery and addiction, how community can profoundly impact those in recovery, and how we can assist those who are in need of psychedelic therapy but may not have access.
Bronze Age Trippers? Hair Strands Shed Light on Europe’s Hallucinogenic Drug Use 3,000 Years Ago
The bronze age psychedelics: hair strands unveil Europe’s earliest recorded hallucinogenic drug use 3000 years ago.
MindCure CEO Kelsey Ramsden – The Psychedelic Space Is Unlike Any Other Drug Development Sector
In this interview with Kelsey Ramsden, CEO on MindCure Health…